Search research articles
Contact Us
Filters
Showing results (171-180 of 284) with videos related to
Page
of 29
Sort By:
Plos One
|
April 12, 2022
Serological testing for SARS-CoV-2 antibodies of employees shows low transmission working in a cancer center
Jeffrey A Meyerhardt, Hong Yue, Radosław P Nowak, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 16, 2019
Real-world treatment patterns and survival of patients with BRAF V600-mutated metastatic non-small cell lung cancer
Leora Horn, Joshua Bauml, Patrick M Forde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2018
Impact of BRAF Mutation Class on Disease Characteristics and Clinical Outcomes in BRAF-mutant Lung Cancer
Ibiayi Dagogo-Jack, Pablo Martinez, Beow Y Yeap, et al.
Journal of Cellular Biochemistry
|
December 6, 2019
From clinical specimens to human cancer preclinical models-a journey the NCI-cell line database-25 years later
James L Mulshine, Peter Ujhazy, Melissa Antman, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 19, 2017
An open-label, phase II study of the polo-like kinase-1 (Plk-1) inhibitor, BI 2536, in patients with relapsed small cell lung cancer (SCLC)
Mark M Awad, Quincy S-C Chu, Leena Gandhi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 10, 2003
Induction docetaxel and carboplatin followed by weekly docetaxel and carboplatin with concurrent radiotherapy, then surgery in stage III non-small cell lung cancer: a Phase I study
Lori J Wirth, Joan Lucca, Patricia Ostler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2009
Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population
Scott J Rodig, Mari Mino-Kenudson, Sanja Dacic, et al.
Cancer Research
|
September 26, 2013
Cetuximab response of lung cancer-derived EGF receptor mutants is associated with asymmetric dimerization
Jeonghee Cho, Liang Chen, Naveen Sangji, et al.
Journal of the National Cancer Institute
|
September 22, 2020
The Impact of COVID-19 on Clinical Trial Execution at the Dana-Farber Cancer Institute
Sara M Tolaney, Christine A Lydon, Tianyu Li, et al.
The Oncologist
|
July 13, 2024
Calls to action on lung cancer management and research
May-Lucie Meyer, Fred R Hirsch, Paul A Bunn, et al.
Page
of 29
Search research articles
Search
Showing results (171-180 of 284) with videos related to
Sort By:
Page
of 29
Plos One
|
April 12, 2022
Serological testing for SARS-CoV-2 antibodies of employees shows low transmission working in a cancer center
Jeffrey A Meyerhardt, Hong Yue, Radosław P Nowak, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 16, 2019
Real-world treatment patterns and survival of patients with BRAF V600-mutated metastatic non-small cell lung cancer
Leora Horn, Joshua Bauml, Patrick M Forde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2018
Impact of BRAF Mutation Class on Disease Characteristics and Clinical Outcomes in BRAF-mutant Lung Cancer
Ibiayi Dagogo-Jack, Pablo Martinez, Beow Y Yeap, et al.
Journal of Cellular Biochemistry
|
December 6, 2019
From clinical specimens to human cancer preclinical models-a journey the NCI-cell line database-25 years later
James L Mulshine, Peter Ujhazy, Melissa Antman, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 19, 2017
An open-label, phase II study of the polo-like kinase-1 (Plk-1) inhibitor, BI 2536, in patients with relapsed small cell lung cancer (SCLC)
Mark M Awad, Quincy S-C Chu, Leena Gandhi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 10, 2003
Induction docetaxel and carboplatin followed by weekly docetaxel and carboplatin with concurrent radiotherapy, then surgery in stage III non-small cell lung cancer: a Phase I study
Lori J Wirth, Joan Lucca, Patricia Ostler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2009
Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population
Scott J Rodig, Mari Mino-Kenudson, Sanja Dacic, et al.
Cancer Research
|
September 26, 2013
Cetuximab response of lung cancer-derived EGF receptor mutants is associated with asymmetric dimerization
Jeonghee Cho, Liang Chen, Naveen Sangji, et al.
Journal of the National Cancer Institute
|
September 22, 2020
The Impact of COVID-19 on Clinical Trial Execution at the Dana-Farber Cancer Institute
Sara M Tolaney, Christine A Lydon, Tianyu Li, et al.
The Oncologist
|
July 13, 2024
Calls to action on lung cancer management and research
May-Lucie Meyer, Fred R Hirsch, Paul A Bunn, et al.
Page
of 29